Our findings provide strong evidence that positive or negative modulation of RhoA activity increases HeLa cell's sensitivity to γ-radiation treatment and therefore points to a possible clinical association of chemotherapy, using RhoA inhibitors, followed by radiotherapy sections for different stages of cervical cancers. Here, RHOA is linked to cervical cancer.